Maruti Suzuki India Ltd - Research Report


Private Client Research




Automobiles - Passenger Cars


Maruti Suzuki India Ltd

Reco Price
Rs. 4950.00
Price Target (1 Year)
Rs. 5934.00


Aug 02, 2016
CNX Nifty




GST implementation and strong monsoon will drive future growth.

Nexa expansion, aggressive R&D spend to continue:
Maruti Suzuki India Ltd (MSIL) outlined a capex of Rs 4500 crores for FY17 to be funded from internal cash flows. Of this it will invest around Rs 2000 crores for R&D and Rs 1100 crores for expanding its premium car showroom ‘Nexa’. Nexa contributes 10% of MSIL’s revenue now. MSIL recently launched its first small truck for which it incurred a capex of Rs 300 crores. It is committed to two new launches until FY 20. This will take it to its aspiration of a 50% market share from the current 46.2% as of Q1FY17. It is moving steadily into the premium segment with cars of higher ASP and better services, offered through Nexa showrooms.

Strong Player:
MSIL is largest maker of passenger vehicles in India. It has capacity of 1.45m vehicles p.a. with a 95% utilization. Expect market-share gains with new launches. MSIL’s volume sales increased by nearly 30% in last two years supported by due tone models and increasing premium showrooms, filling gaps in the SUV line, and better distribution in rural areas. MSIL has maintained its market leadership despite the increase in competitive intensity. Despite 18 players being in the fray fighting for the 2.6 million large market, MSIL has managed to increase its market share from 42% in FY14 to 47% in FY16. The financial performance has been strong over the past years with operating margins maintained at decent levels. On the business levers side, it is performing well on all factors, ranging from cost of car ownership to demographics to new product launches led by S-Cross, Baleno and Vitara Brezza. However, in the near term, given the capacity constraint and exports expected to be flat, we have estimated volume growth of 10.5%, 13.90% for FY17E, FY18E, respectively.

Structural positives outweigh near term hurdle of capacity constraint:
MSIL has a near term hurdle of capacity constraint as its aggregate production capacity is at 1.45m and the Gujarat plant (to be commissioned in January 2017) will hardly contribute in FY17E (10,000 units in Q4FY17E). However, there are a lot of favorable demand variables for MSIL in terms of macro tailwinds like interest rates, normal monsoon, rural demand (rural sales contribute 35% of MSIL sales) and Seventh Pay Commission impact (MSIL biggest beneficiary as it has highest market share in the first time buyer segment). MSIL will also benefit on the regulation front, as the implementation of GST will result in drop of ASPs (4-5% drop due to lower taxation) for MSIL’s cars. The implementation of proposed emission norms (BS-6) will have the least cost impact on MSIL (2% rise in ASP) due to their highest exposure to small petrol cars. Lastly, MSIL has been aggressive in terms of adding more content in car (airbags/ABS in base models, launching ‘smart hybrids’ variants & automatic transmission option in its models).

Export performance to moderate in near-term:
Suzuki is aiming to let MSIL grow as a low-cost brand to target markets such as Africa. MSIL already contributes 45% to Suzuki’s global profits. As such, Suzuki’s strategy to make MSIL its global export hub for low priced products is logical. Currently, exports form 9% of the total sales for MSIL. Export volumes are expected to be flat in FY17E. The decline in volumes in the Sri Lankan market is expected to be offset by growth in export of Baleno. Going ahead, we have taken 9% CAGR in FY16-18E in export volumes.

Stock Data

CMP (Rs)
Face value (Rs)
52 Week Range (Rs)
4885.00 - 3193.25
Market cap (Rs Crores)
Price To Book Value (x)
P/E Ratio (x)

One Year indexed Stock Performance

Maruti Suzuki India LtdSensex
Maruti Suzuki India Ltd
Return (%)


(in %)

+91 22 6639 3000



The Indian auto industry is one of the largest in the world. The industry accounts for 7.1% of the country's Gross Domestic Product (GDP). As of FY 2014-15, around 31 per cent of small cars sold globally are manufactured in India.

The Two Wheelers segment with 81% market share is the leader of the Indian Automobile market owing to a growing middle class and a young population. Moreover, the growing interest of the companies in exploring the rural markets further aided the growth of the sector. The overall Passenger Vehicle (PV) segment has 13% market share.

India is also a prominent auto exporter and has strong export growth expectations for the near future. In April-January 2016, exports of Commercial Vehicles registered a growth of 18.36% over April-January 2015. In addition, several initiatives by the Government of India and the major automobile players in the Indian market are expected to make India a leader in the Two Wheeler (2W) and Four Wheeler (4W) market in the world by 2020.


Maruti Suzuki India Limited is an India-based company engaged in the manufacture, purchase and sale of motor vehicles, components and spare parts (automobiles). The company's other activities consist of facilitation of pre-owned car sales, fleet management and car financing. The company's vehicle portfolio includes Alto 800, Alto K10, Wagon R, Celerio, Ritz, Swift, DZire, Ertiga, Omni, Eeco, Gypsy and Ciaz. The company's other services include Maruti Finance, Maruti Insurance, Maruti Genuine Accessories, Maruti Genuine Parts, Maruti Driving School and Maruti Auto card. Its holding company is Suzuki Motor Corporation. The company's subsidiaries include Maruti Insurance Business Agency Limited, Maruti Insurance Distribution Services Limited, True Value Solutions Limited, Maruti Insurance Agency Network Limited, Maruti Insurance Agency Solutions Limited, Maruti Insurance Agency Services Limited and Maruti Insurance Broker Limited.

Profit & Loss Statement:- (Consolidated)
(Rs Crores)
  • Net Sales
  • Growth (%)
  • Total Expenditure
  • Margin (%)
  • Other Income
  • Operating Profit
  • Interest
  • PBDT
  • Depreciation
  • Profit Before Tax
  • Provision for Tax
  • Profit After Tax
  • Margin (%)
  • Adjusted EPS
  • 44541.80
  • -
  • 39281.10
  • 5260.70
  • 11.81
  • 773.60
  • 6034.30
  • 184.50
  • 5849.80
  • 2116.00
  • 3733.80
  • 902.20
  • 2831.60
  • 6.36
  • 94.47
  • 50801.40
  • 14.05
  • 44026.40
  • 6775.00
  • 13.34
  • 934.10
  • 7709.10
  • 217.80
  • 7491.30
  • 2515.30
  • 4976.00
  • 1185.40
  • 3790.60
  • 7.46
  • 126.07
  • 58612.00
  • 15.37
  • 49553.40
  • 9058.60
  • 15.46
  • 531.70
  • 9590.30
  • 93.70
  • 9496.60
  • 2867.00
  • 6629.60
  • 1998.70
  • 4630.90
  • 7.90
  • 155.59
  • 65010.00
  • 10.92
  • 53850.00
  • 11160.00
  • 17.17
  • 500.00
  • 11660.00
  • 100.00
  • 11560.00
  • 2968.00
  • 8592.00
  • 2590.327
  • 6001.67
  • 9.23
  • 201.64
  • 74060.50
  • 13.92
  • 61150.00
  • 12910.50
  • 17.43
  • 500.00
  • 13410.50
  • 100.00
  • 13310.50
  • 3550.00
  • 9760.50
  • 2942.608
  • 6817.89
  • 9.21
  • 229.07
Source: Stockaxis Research, Company Data


We remain positive on MSIL on expectations of market share gains and good demand growth driving revenues. Healthy product portfolio and the opportunity to reap benefits from recent launches have been well received in the market. We are expecting a pick-up in spending due to good monsoon and 7th pay commission pay which are likely to be key triggers for the company. The Gujarat plant will be commissioned in January 2017 and will contribute in terms of volumes for FY17E (10000 units in Q4FY17E). The plant will see a full ramp up in about six months. At a CMP of Rs 4950, we recommend a “BUY” rating on the stock at 25.90x FY18E with a target price of Rs 5934 two years down the line.



Opulent Investment Adviser Private Limited is registered as an Investment Adviser with SEBI bearing registration Number INA000002462 as per Securities and Exchange Board of India (Investment Advisers) Regulations, 2013. Opulent Investment Adviser Private Limited offer investment advisory services to clients as well as prospects.

The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.

Other disclosures by Opulent Investment Adviser Private Limited and its Research Analyst with reference to the subject company(s) covered in this report-:

Opulent Investment Adviser Private Limited does have any financial interest in the subject company: (NO)

Research Analyst or his/her relative’s have financial interest in the subject company: (NO)

Opulent Investment Adviser Private Limited and Research Analyst or his/her relative’s does have any material conflict of interest in the subject company: (NO)

Research Analyst or his/her relatives have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research Report: (NO)

The research Analyst has served as officer, director or employee of the subject company: (NO)

Our salespeople and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein.

This report is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person.

This report is not to be construed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It is for the general information of the users of / Opulent Investment Adviser Private Limited.

While reasonable care has been taken in the preparation of this report, it does not purport to be a complete description of the securities, markets or developments referred to herein, and we do not warrant its accuracy or completeness.

Opulent Investment Adviser Private Limited, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report.